Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 16, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
GE Healthcare Launches Xuri™ IL-2 Growth Factor
Thursday, May 15, 2014
Xuri™ IL-2 for the reliable activation and expansion of T-lymphocytes.

Hologic’s New Tomcat Pre-analytical Sample Processing Instrument to be Featured at ASM2014
Thursday, May 15, 2014
The instrument streamlines laboratory workflow by providing automated processing of liquid-based cytology samples.

Bio-Rad Introduces New CytoTrack™ Cell Proliferation Assays
Saturday, May 10, 2014
Easy, longer-lasting staining of live cells for multicolor flow cytometry experiments.

Leica Microsystems and MBF Bioscience Announce a Partnership
Saturday, May 10, 2014
Leica Microsystems’ microscopes can now fully integrate with Neurolucida and Stereo Investigator software for analyzing cells in neuroscience research.

CATIM in Association with Phasefocus Hosts a Two-Day Workshop
Thursday, May 08, 2014
Workshop on label-free cell imaging to present on Tuesday 24th and Wednesday 25th June.

Exiqon Launches Exosome Isolation Kits for Analysis of Biofluids
Thursday, May 08, 2014
miRCURY™ Exosome Isolation kits ensure exosomes recovery in less than two hours.

Quantitative Imaging Mode of the NanoWizard 3
Thursday, May 01, 2014
JPK Instruments reports on the use of the Quantitative Imaging mode for tissue engineering studies at Niigata University.

New XFe96 Spheroid Microplate from Seahorse Bioscience
Tuesday, April 22, 2014
The microplate enables functional, metabolic measurement of in vitro tumor spheroids.

Leica Microsystems Celebrates 10 Years of Super-Resolution Innovations
Wednesday, April 16, 2014
Leica TCS SP8 STED 3X introduction in 2014 marks Company’s 10th anniversary.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 237
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv